Skip to main content

Part of the book series: Methods in Molecular Medicine™ ((MIMM,volume 92))

  • 787 Accesses

Abstract

Cystic fibrosis (CF) is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene (1,2). More than 1000 disease mutations and 200 polymorphisms have been identified in the CFTR gene (3). The type and frequency of mutations is very variable from ethnic population to population (4). The most common mutation, F508del (e.g., ΔF508 according to the old nomenclature), reaches frequencies of about 70% in Northern European populations. Besides F508del, other common mutations exist in most populations, each reaching frequencies of approx 1–2%. Examples include the 1717-1G→A, G542X, G551D, R553X, W1282X, and N1303K mutations. Finally, for a given ethnic population, “ethnic-specific” mutation(s) that reach frequencies of more than 1–2% might exist. For most ethnic populations, “common” mutations cover about 85% of all mutant CFTR genes. The remaining group of mutant CFTR genes in a particular ethnic population comprises rare mutations, some of them only found in a single family. Moreover, when one of the more common mutations is not found in a patient, a mutation is likely to be present that has never been detected before in that ethnic population. It is therefore very difficult to set up a strategy for a general screening of CFTR mutations, which allow sensitivities close to 100%, even in a well-characterized ethnic population.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Riordan, J. R., Rommens, J. M., Kerem, B. S., Alon, N., Rozmahel, R., Grzelczak, Z., et al. (1989) Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245, 1066–1073.

    Article  PubMed  CAS  Google Scholar 

  2. Zielenski, J., Rozmahel, R., Bozon, D., Kerem, B.-S., Grzelczak, Z., Riordan, J. R., et al. (1991) Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Genomics 10, 214–228.

    Article  PubMed  CAS  Google Scholar 

  3. The Cystic Fibrosis Genetic Analysis Consortium. Cystic Fibrosis Mutation Database. http://www.genet.sickkids.on.ca/cftr/

  4. Dequeker, E., Cuppens, H., Dodge, J., Estivill, X., Goossens, M., Pignatti, P. F., et al. (2000) Recommendations for quality improvement in genetic testing for cystic fibrosis. European Concerted Action on Cystic Fibrosis. Eur. J. Hum. Genet. 8(Sp 2), S2–S24.

    Article  PubMed  CAS  Google Scholar 

  5. Dequeker, E. and Cassiman, J. J. (2000) Genetic testing and quality control in diagnostic laboratories. Nat. Genet. 25, 259–260.

    Article  PubMed  CAS  Google Scholar 

  6. Grody, W. W., Cutting, G. R., Klinger, K. W., Richards, C. S., Watson, M. S., and Desnick, R. J. (2001) Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Genetics in Medicine 3, 149–154.

    Article  PubMed  CAS  Google Scholar 

  7. Costes, B., Fanen, P., Goossens, M., and Ghanem, N. (1993) A rapid, efficient, and sensitive assay for simultaneous detection of multiple cystic fibrosis mutations. Hum. Mutat. 2, 185–191.

    Article  PubMed  CAS  Google Scholar 

  8. Cuppens, H. and Cassiman, J.-J. (2001) Solid phase fluorescent sequencing of the CFTR gene, in DNA Sequencing Protocols (Graham, C. A. and Hill, A. J. M., eds.), Humana Press, Totowa, NJ, pp. 63–88.

    Chapter  Google Scholar 

  9. Le Maréchal, C, Audrézet, M. P., Quéré, I., Raguénès, O., Langonné, S., and Férec, C. (2001) Complete and rapid scanning of the cystic fibrosis transmembrane conductance regulator (CFTR) gene by denaturing high-performance liquid chromatography (D-HPLC): major implications for genetic counselling. Hum. Genet. 108, 290–298.

    Article  PubMed  Google Scholar 

  10. Zielenski, J., Patrizio, P., Corey, M., Handelin, B., Markiewicz, D., Asch, R., et al. (1995) CFTR gene variant for patients with congenital absence of vas deferens. Am. J. Hum. Genet. 57, 958–960.

    PubMed  CAS  Google Scholar 

  11. Chillón, M., Casals, T, Mercier, B., Bassas, L., Lissens, W., Silber, S., et al. (1995) Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. N. Engl. J. Med. 332, 1475–1480.

    Article  PubMed  Google Scholar 

  12. Pignatti, P. F., Bombieri, C, Marigo, C, Benetazzo, M., and Luisetti, M. (1995) Increased incidence of cystic fibrosis gene mutations in adults with disseminated bronchiectasis. Hum. Mol. Genet. 4, 635–639.

    Article  PubMed  CAS  Google Scholar 

  13. Sharer, N., Schwarz, M., Malone, G., Howarth, A., Painter, J., Super, M., et al. (1998) Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N. Engl. J. Med. 339, 645–652.

    Article  PubMed  CAS  Google Scholar 

  14. Chu, C.-S., Trapnell, B. C, Curristin, S., Cutting, G. R., and Crystal, R. G. (1993) Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA. Nat. Genet. 3, 151–156.

    Article  PubMed  CAS  Google Scholar 

  15. Cuppens, H., Lin, W., Jaspers, M., Costes, B., Teng, H., Vankeerberghen, A., et al. (1998) Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes—The polymorphic (TG)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation. J. Clin. Investig. 101, 487–496.

    Article  PubMed  CAS  Google Scholar 

  16. Kiesewetter, S., Macek, M. Jr., Davis, C, Curristin, S. M., Chu, C.-S., Graham, C, et al. (1993) A mutation in CFTR produces different phenotypes depending on chromosomal background. Nat. Genet. 5, 274–278.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Humana Press Inc.

About this protocol

Cite this protocol

Cuppens, H., Dequeker, E., Cassiman, JJ. (2004). Cystic Fibrosis. In: Elles, R., Mountford, R. (eds) Molecular Diagnosis of Genetic Diseases. Methods in Molecular Medicine™, vol 92. Humana Press, Totowa, NJ. https://doi.org/10.1385/1-59259-432-8:221

Download citation

  • DOI: https://doi.org/10.1385/1-59259-432-8:221

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-0-89603-932-2

  • Online ISBN: 978-1-59259-432-0

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics